Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinicopathologic features, tumor immune microenvironment and genomic landscape of Epstein-Barr virus-associated intrahepatic cholangiocarcinoma
Yuhua Huang, Chris Zhiyi Zhang, Qunsheng Huang, et al.
Journal of Hepatology (2020) Vol. 74, Iss. 4, pp. 838-849
Open Access | Times Cited: 82

Showing 1-25 of 82 citing articles:

Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition)
Jian Zhou, Hui‐Chuan Sun, Zheng Wang, et al.
Liver Cancer (2023) Vol. 12, Iss. 5, pp. 405-444
Open Access | Times Cited: 191
Immunology and immunotherapy of cholangiocarcinoma
Tim F. Greten, Robert F. Schwabe, Nabeel Bardeesy, et al.
Nature Reviews Gastroenterology & Hepatology (2023) Vol. 20, Iss. 6, pp. 349-365
Closed Access | Times Cited: 90
The role of tumor-infiltrating lymphocytes in cholangiocarcinoma
Dong Liu, Lara R. Heij, Zoltán Czigány, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 89
Efficacy and predictive biomarkers of immunotherapy in Epstein-Barr virus-associated gastric cancer
Yuezong Bai, Tong Xie, Zhenghang Wang, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 3, pp. e004080-e004080
Open Access | Times Cited: 67
Clinical relevance of biomarkers in cholangiocarcinoma: critical revision and future directions
Rocı́o I.R. Macı́as, Vincenzo Cardinale, Timothy J. Kendall, et al.
Gut (2022), pp. gutjnl-327099
Open Access | Times Cited: 52
Geospatial Immune Heterogeneity Reflects the Diverse Tumor–Immune Interactions in Intrahepatic Cholangiocarcinoma
Youpei Lin, Lihua Peng, Liangqing Dong, et al.
Cancer Discovery (2022) Vol. 12, Iss. 10, pp. 2350-2371
Open Access | Times Cited: 50
Rational development of combination therapies for biliary tract cancers
James J. Harding, Danny N. Khalil, Luca Fabris, et al.
Journal of Hepatology (2022) Vol. 78, Iss. 1, pp. 217-228
Closed Access | Times Cited: 41
Immunotherapeutic approaches in EBV-associated nasopharyngeal carcinoma
Wenting Li, Xiaobing Duan, Xingxing Chen, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 40
MYH7 in cardiomyopathy and skeletal muscle myopathy
Gao Yuan, Lu Peng, Cuifen Zhao
Molecular and Cellular Biochemistry (2023) Vol. 479, Iss. 2, pp. 393-417
Closed Access | Times Cited: 23
Causal relationship between immune cell phenotypes and risk of biliary tract cancer: evidence from Mendelian randomization analysis
YaLan Hu, Kui Wang, Yuhua Chen, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 9
Epstein–Barr Virus—Associated Malignancies and Immune Escape: The Role of the Tumor Microenvironment and Tumor Cell Evasion Strategies
Marcus Bauer, Simon Jasinski‐Bergner, Ofer Mandelboim, et al.
Cancers (2021) Vol. 13, Iss. 20, pp. 5189-5189
Open Access | Times Cited: 54
Lacking Immunotherapy Biomarkers for Biliary Tract Cancer: A Comprehensive Systematic Literature Review and Meta-Analysis
Giorgio Frega, Fernando P. Cossío, Jesús M. Bañales, et al.
Cells (2023) Vol. 12, Iss. 16, pp. 2098-2098
Open Access | Times Cited: 20
Characterization of tumor microbiome and associations with prognosis in intrahepatic cholangiocarcinoma
Haoyang Xin, Jixue Zou, Rongqi Sun, et al.
Journal of Gastroenterology (2024) Vol. 59, Iss. 5, pp. 411-423
Closed Access | Times Cited: 8
A cuproptosis-related gene expression signature predicting clinical prognosis and immune responses in intrahepatic cholangiocarcinoma detected by single-cell RNA sequence analysis
Hefei Ren, Chang Liu, Cheng Zhang, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
Immunosuppressive Tumor Microenvironment and Immunotherapy of Epstein–Barr Virus-Associated Malignancies
Xueyi Zheng, Yuhua Huang, Kai Li, et al.
Viruses (2022) Vol. 14, Iss. 5, pp. 1017-1017
Open Access | Times Cited: 27
Tumor Microenvironment and its Implications for Antitumor Immunity in Cholangiocarcinoma: Future Perspectives for Novel Therapies
Hengsong Cao, Tian Huang, Mingrui Dai, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 14, pp. 5369-5390
Open Access | Times Cited: 27
Pathological, molecular, and clinical characteristics of cholangiocarcinoma: A comprehensive review
Mukul Vij, Yogesh Puri, Ashwin Rammohan, et al.
World Journal of Gastrointestinal Oncology (2022) Vol. 14, Iss. 3, pp. 607-627
Open Access | Times Cited: 24
Immunotherapy and targeted therapy for cholangiocarcinoma: Artificial intelligence research in imaging
Jiong Liu, Jian Shu
Critical Reviews in Oncology/Hematology (2024) Vol. 194, pp. 104235-104235
Closed Access | Times Cited: 5
Unveiling the promise of PD1/PD-L1: A new dawn in immunotherapy for cholangiocarcinoma
Fei Chen, Jian Sheng, Xiaoping Li, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116659-116659
Open Access | Times Cited: 5
Virus-like particle-based multipathogen vaccine of FMD and SVA elicits balanced and broad protective efficacy in mice and pigs
Hetao Song, Sahibzada Waheed Abdullah, Shuanghui Yin, et al.
Vaccine (2024) Vol. 42, Iss. 18, pp. 3789-3801
Open Access | Times Cited: 5
Immunotherapy of cholangiocarcinoma: Therapeutic strategies and predictive biomarkers
Ruyin Chen, Dandan Zheng, Qiong Li, et al.
Cancer Letters (2022) Vol. 546, pp. 215853-215853
Closed Access | Times Cited: 21
The immune microenvironment features and response to immunotherapy in EBV-associated lymphoepithelioma-like cholangiocarcinoma
Nai‐Jung Chiang, Ya‐Chin Hou, Kien Thiam Tan, et al.
Hepatology International (2022) Vol. 16, Iss. 5, pp. 1137-1149
Closed Access | Times Cited: 19
Expert Consensus on Pathological Diagnosis of Intrahepatic Cholangiocarcinoma (2022 version)
Han Wang, Jun Chen, Xin Zhang, et al.
Journal of Clinical and Translational Hepatology (2023) Vol. 11, Iss. 7, pp. 1553-1564
Open Access | Times Cited: 12
Advancing Cholangiocarcinoma Care: Insights and Innovations in T Cell Therapy
Neda Dadgar, Arun Kumar Arunachalam, Hanna Hong, et al.
Cancers (2024) Vol. 16, Iss. 18, pp. 3232-3232
Open Access | Times Cited: 4
EBV enhances immunotherapy sensitivity in intrahepatic cholangiocarcinoma through cGAS-STING pathway activation
Lingli Huang, Qian Zhong, Silan Huang, et al.
Hepatology Communications (2025) Vol. 9, Iss. 4
Open Access
Page 1 - Next Page

Scroll to top